Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report

This case underscores that the combination therapy of secukinumab and apremilast can offer a promising approach for the long-term management of ACH.

Authors

Institutions

Publication Details

Journal
Clinical Cosmetic and Investigational Dermatology
Published
2025-05-01
DOI
https://doi.org/10.2147/ccid.s519344
Citations
2
Primary Topic
Skin and Cellular Biology Research
Type
article
Field-Weighted Citation Impact
2.30
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report

Chunhui Yuan, Lyu-Ye Liu, Jing Yuan, Junling Zhang et al.
2 citations
Clinical Cosmetic and Investigational Dermatology
Skin and Cellular Biology Research
2.30
article

Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report

Chunhui Yuan, Lyu-Ye Liu, Jing Yuan, Junling Zhang, Xingxing Yao
article en
2 citations

Abstract

This case underscores that the combination therapy of secukinumab and apremilast can offer a promising approach for the long-term management of ACH.

Clinical Cosmetic and Investigational DermatologyVol. Volume 18
Tianjin University of Traditional Chinese Medicine (CN), Tianjin Hospital (CN)
Zero hunger
Openalex Percentile: Top 14%
Skin and Cellular Biology Research
2.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.